Skip to main content
WEDNESDAY,
MAY 25, 2022
WEDNESDAY,
MAY 25, 2022
Home
Economy
Stocks
Analysis
World+Biz
Sports
Splash
Features
Videos
Long Read
Games
Epaper
More
COVID-19
Bangladesh
Infograph
Interviews
Offbeat
Thoughts
Podcast
Quiz
Tech
Subscribe
Archive
Trial By Trivia
Magazine
Supplement
বাংলা
J&J
Coronavirus chronicle
No Omicron deaths in J&J vaccine study in South Africa, scientist says
Global Economy
Healthcare giant Johnson & Johnson to split into two companies
Coronavirus chronicle
US brokers J&J-COVAX deal to send vaccines to conflict zones -Blinken
USA
J&J settles most Risperdal lawsuits, with $800 million in expenses
Coronavirus chronicle
US FDA clears Moderna, J&J Covid-19 boosters, backs use of different vaccine for boost
Coronavirus chronicle
Moderna or Pfizer booster works better for people vaccinated with J&J: study
USA
Six US states do not join $26 billion opioid settlements with distributors, J&J
Coronavirus chronicle
J&J says US FDA agrees to extend shelf life of its Covid-19 vaccine
World+Biz
J&J exploring putting talc liabilities into bankruptcy
World+Biz
J&J reaches $230 mln opioid settlement with New York state
Panorama
The real vaccine crisis isn’t about J&J or AstraZeneca
Coronavirus chronicle
J&J to deliver Covid vaccine to Europe from April 19
Coronavirus chronicle
US to distribute 4 million J&J Covid vaccines by Tuesday
Show More